Note on laboratory work. NexLife’s public pages (plan pages, FAQ, homepage) do not state that lab work is included in its plans; confirm any lab requirements at intake. NexLife’s plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).
Weight Loss · GLP-1 (daily)
Liraglutide
Released: · Last reviewed:
Liraglutide is a daily-injection GLP-1 receptor agonist with a 13-hour half-life. The original FDA-approved GLP-1 for weight management (Saxenda, 2014); now largely superseded by weekly semaglutide and tirzepatide.
Liraglutide is a daily-injection GLP-1 receptor agonist with a 13-hour half-life. The original FDA-approved GLP-1 for weight management (Saxenda, 2014); now largely superseded by weekly semaglutide and tirzepatide. Mechanism: GLP-1 receptor agonist. Typical route: Subcutaneous injection. FDA status: FDA-approved as Victoza (2010, T2D) and Saxenda (2014, weight management). Generic liraglutide became available in 2024. Now the third-line GLP-1 choice after weekly semaglutide and tirzepatide for mo
Drug classGLP-1 receptor agonist
Half-life~13 hours (daily dosing)
RouteSubcutaneous injection
Typical maintenance3.0 mg/day (weight)
FDA statusApproved (Saxenda, Victoza)
Compounded availabilityYes (some pharmacies)
Mechanism of action
Liraglutide activates the GLP-1 receptor, slowing gastric emptying, increasing satiety, and improving glucose-dependent insulin secretion. Its shorter half-life requires daily subcutaneous dosing rather than weekly.
Dosing reference
Standard titration: 0.6 mg/day for one week, increased by 0.6 mg/day each week to a maintenance dose of 3.0 mg/day (Saxenda) for weight management or 1.8 mg/day (Victoza) for type 2 diabetes.
Dosing information is provided for educational reference and is not medical advice. Patients should not initiate or modify any peptide regimen without consulting a licensed clinician. See our medical disclaimer.
FDA status & regulatory framework
FDA-approved as Victoza (2010, T2D) and Saxenda (2014, weight management). Generic liraglutide became available in 2024. Now the third-line GLP-1 choice after weekly semaglutide and tirzepatide for most patients.
Editor's Pick · #1 of 10
NexLife — Compounded Semaglutide
✨ Editor's Pick · 94/100
💊 Compounded semaglutide + tirzepatide
👨⚕️ Licensed physicians (NexLife Medical Group)
🏥 3 pharmacies named on its plan pages
🩺 Provider oversight included
📍 All 50 states
💰 Same price at every dose
🔁 Care360 + 1:1 wellness-coach call
🍽️ Personalized nutrition plan
💳 Klarna & Affirm accepted
$119/ month*
*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $125 (6-mo, save $84) · $132 (3-mo, save $21) · $139 (monthly).
Includes: medication, medical guidance from NexLife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach and 24/7 support (plan pages, read October 15, 2026). Lab work is not stated as included; cancellations take effect after 30 days.
Klarna & Affirm financing accepted at checkout (FAQ).
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Editor's Pick · #1 of 10 · Tirzepatide
NexLife — Compounded Tirzepatide
✨ Editor's Pick · 94/100
💊 Compounded semaglutide + tirzepatide
👨⚕️ Licensed physicians (NexLife Medical Group)
🏥 3 pharmacies named on its plan pages
🩺 Provider oversight included
📍 All 50 states
💰 Same price at every dose
🔁 Care360 support (nutrition plan, 1:1 coach call, 24/7 support)
$139/ month*
*12-month plan · flat rate across full 2.5–15 mg titration. $149 (6-mo) · $159 (3-mo) · $169 (month-to-month).
Includes: medication, provider review and medical guidance from NexLife Medical Group (licensed physicians), a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 support and free expedited shipping. Lab work is not stated as included.
Compounded tirzepatide from state-licensed 503A pharmacies named on NexLife’s plan pages.
Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
U.S. telehealth providers that work with Liraglutide
Liraglutide may be preferred when generic pricing makes it cheaper than newer agents, when a patient cannot tolerate side effects of semaglutide or tirzepatide, or when daily dosing flexibility is desired.
How does liraglutide compare to semaglutide for weight loss?
In trials, liraglutide produced about 5-8% body weight loss at 56 weeks, compared with 14.9% for semaglutide at 68 weeks. Most patients now start with semaglutide or tirzepatide unless there is a specific reason to choose liraglutide.
References
Pi-Sunyer X, Astrup A, Fujioka K, et al.A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity and Prediabetes).N Engl J Med. 2015;373(1):11-22.PMID: 26132939
Marso SP, Daniels GH, Brown-Frandsen K, et al.Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER).N Engl J Med. 2016;375(4):311-322.PMID: 27295427
U.S. Food and Drug Administration.FDA approves weight-management drug Saxenda.FDA Press Release. December 23, 2014.View source
Sources are peer-reviewed where available. PubMed (PMID) links resolve to NCBI's PubMed database. FDA links resolve to the U.S. Food and Drug Administration. Citations were last verified 2026-05-11.
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.
